Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investmentby Mark Eisenberg 12.02.2024Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
SU Group Holdings Wins Major Hong Kong Security Projectby Lilu Anderson 12.02.2024SU Group Holdings Limited announces a prestigious security system contract in Hong Kong, showcasing their expertise and potential for growth.
Martin Marietta’s Bold Acquisition Boosts SE Footprintby Mark Eisenberg 12.02.2024Martin Marietta Materials is set to acquire 20 aggregates operations from Blue Water Industries for $2.05 billion, expanding its footprint ...
Fed Moves Spark Market Uncertaintyby Terry Bingman 12.02.2024The Dow Jones ends the week with minimal changes, while the Nasdaq approaches a record high. Fed officials highlight the ...
Apple’s AI-Driven iPhone Boost Spurs Stock Growthby Lilu Anderson 12.02.2024Analysts predict AI-integrated iPhones could boost Apple's stock and sales, potentially leading to more device replacements and revenue opportunities.
Hasbro Q4 Earnings: Recovery or Stagnation Ahead?by Mark Eisenberg 12.02.2024Hasbro is set to release its Q4 results, with a predicted profit increase but a 20% decline in revenue. Analysts ...
Monday.com Surpasses Q4 Earnings Estimates, Stock Prices Surgeby Lilu Anderson 12.02.2024Monday.com, the project management software company, reported strong Q4 2023 earnings, exceeding expectations. Revenue rose by 35%, and stock surged ...
Pegasystems Q4 Results: Analysts Optimisticby Lilu Anderson 12.02.2024Pegasystems is expected to announce strong fourth-quarter results, supported by stable spending and ongoing digital transformation initiatives. Analysts believe in ...
Oppenheimer Trims Gilead Sciences Price Targetby Mark Eisenberg 12.02.2024Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
Take-Two Stock: Wolfe Cuts Price with GTA Delaysby Mark Eisenberg 12.02.2024Take-Two Interactive's price target is adjusted to $180 by Wolfe Research, citing strong performance and potential for earnings growth.